Pfizer Investigational Site — Kansas City, Missouri

Pfizer Investigational Site is a clinical research site located in Kansas City, Missouri, United States 64114.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Pfizer Investigational Site has participated in 59 clinical trials.

Therapeutic areas: Fibromyalgia, Carcinoma, Renal Cell, Kidney Neoplasms.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Pfizer, ViiV Healthcare.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pfizer Investigational Site?

Pfizer Investigational Site has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pfizer Investigational Site conducted?

Pfizer Investigational Site has 59 clinical trials on record. Their work covers Fibromyalgia, Carcinoma, Renal Cell, Kidney Neoplasms.

Is Pfizer Investigational Site accredited by Crixeo Health?

Yes — Pfizer Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Pfizer Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.